Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96FG2: Variant p.Leu265Ser

ELMO domain-containing protein 3
Gene: ELMOD3
Feedback?
Variant information Variant position: help 265 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Leucine (L) to Serine (S) at position 265 (L265S, p.Leu265Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (L) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In DFNB88; perturbed subcellular location with loss of targeting to stereocilia and concentration in the nucleus; loss of ARL2 GAP activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 265 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 381 The length of the canonical sequence.
Location on the sequence: help IQQFPFCLMSVNITHIAIQA L REECLSRECNRQQKVIPVVN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         IQQFPFCLMSVNITHIAIQALREECLSRECNRQQKVIPVVN

Mouse                         IQQFPFCLMSVNITRIAIQALREECLSRECNRRQKVIPVVN

Rat                           IQQFPFCLMSVNITRIAIQALREECLSRECNRRRKVIPVVN

Bovine                        IQQFPFCLMSVNITRIAIQALREECLSRECNRQQKVIPVVN

Caenorhabditis elegans        PNDFPLAVVSINITSILLTQLKKGALDNFGNEIEGLYPFFS

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 381 ELMO domain-containing protein 3
Domain 170 – 324 ELMO
Alternative sequence 162 – 381 Missing. In isoform 3.
Alternative sequence 186 – 381 Missing. In isoform 5.
Alternative sequence 255 – 381 Missing. In isoform 2.



Literature citations
An alteration in ELMOD3, an Arl2 GTPase-activating protein, is associated with hearing impairment in humans.
Jaworek T.J.; Richard E.M.; Ivanova A.A.; Giese A.P.; Choo D.I.; Khan S.N.; Riazuddin S.; Kahn R.A.; Riazuddin S.;
PLoS Genet. 9:E1003774-E1003774(2013)
Cited for: INVOLVEMENT IN DFNA88; VARIANT DFNB88 SER-265; FUNCTION; SUBCELLULAR LOCATION; IDENTIFICATION OF ISOFORMS 1 AND 6; TISSUE SPECIFICITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.